Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EarkartBOM:544549 -0.81%20 EBIT per Share is ₹3.94 as of Mar. 2026. GuruFocus rates BOM:544549 with a GF Score™ of 20/100. The stock has 4 warning signs investors should review. Among 682 Medical Devices & Instruments companies, Earkart ranks better than 95.75% on this metric.
Earkart's EBIT per Share for the
six
months ended in Mar. 2026 was ₹3.94.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was ₹3.94.
During the past 12 months, the average EBIT per Share Growth Rate of Earkart was -8.40% per year.
During the past 3 years, the average EBIT per Share Growth Rate was 79.10% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Earkart's EBIT per Share or its related term are showing as below:
BOM:544549'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: 79.1 Med: 230.05 Max: 381
Current: 79.1
During the past 5 years, the highest 3-Year average EBIT per Share Growth Rate of Earkart was 381.00% per year. The lowest was 79.10% per year. And the median was 230.05% per year.
BOM:544549's 3-Year EBIT Growth Rate is ranked better than 95.75% of 682
companies
in the Medical Devices & Instruments industry
Industry Median: 9.6
vs BOM:544549: 79.10
Earkart's EBIT for the
six
months ended in Mar. 2026 was ₹48.7 Mil.
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Earkart EBIT per Share Related Terms
Earkart EBIT per Share Historical Data
* Premium members only.
The historical data trend for Earkart's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹3.94
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Earkart (BOM:544549) has a EBIT per Share of ₹3.94 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Earkart and its competitors. According to the industry distribution chart, Earkart ranks #29 out of 682 companies in the Medical Devices & Instruments industry, placing it in the top 4.3%.
Is Earkart's EBIT per Share too high?
Earkart's current EBIT per Share is ₹3.94. Based on the distribution chart, Earkart ranks #29 out of 682 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Earkart has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Earkart's EBIT per Share compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Earkart ranks #29 out of 682 companies for EBIT per Share. This places Earkart in the top 4% of its industry — outperforming the majority of peers. The industry median EBIT per Share is 9.60. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Medical Devices & Instruments company?
The median EBIT per Share among Medical Devices & Instruments companies is 9.60, based on 682 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Earkart and its competitors. For the Medical Devices & Instruments industry, the median EBIT per Share is 9.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Earkart's current EBIT per Share is ₹3.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Earkart stock overvalued right now?
Earkart (BOM:544549) has a current EBIT per Share of ₹3.94. The current EBIT per Share is ₹3.94. Earkart's overall GF Score™ is 20/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Earkart (BOM:544549), the current EBIT per Share is ₹3.94 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Earkart Ltd is a hearing care company based in India that manufactures and distributes modern hearing aids and related accessories at affordable prices. The company also trades in hearing aids and parts from both Indian and foreign brands. Earkart has expanded its product range to include mobility aids like adjustable foldable walkers and therapy kits for children with disabilities. It developed a remote audiometry machine operated by audiologists to facilitate hearing tests remotely, improving access to hearing care services across India. Earkart operates through a wide network of clinics and hearing solution dispensers, blending manufacturing with a customer-focused approach to reach underserved regions.
20GF Score
Get the complete analysis for BOM:544549
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:544549 has been successfully added to your 
